| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,179 |
989 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,132 |
969 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
483 |
364 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
239 |
208 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
293 |
260 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
418 |
358 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
152 |
124 |
$11K |
| 99000 |
|
249 |
233 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
76 |
65 |
$3K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
62 |
59 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
45 |
37 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
91 |
60 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
69 |
65 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
13 |
13 |
$739.22 |
| 81002 |
|
281 |
209 |
$722.80 |
| 81025 |
|
40 |
34 |
$241.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
43 |
31 |
$93.81 |